Today: 7 February 2026
Subscribe

Light & Wonder (LNW) Completes Nasdaq Delisting as ASX CDI Listing, New ESPP and Governance Filings Go Live – 13 November 2025

Light & Wonder (LNW) Completes Nasdaq Delisting as ASX CDI Listing, New ESPP and Governance Filings Go Live – 13 November 2025

Light & Wonder, Inc. has officially wrapped up its U.S. primary listing era. The gaming and iGaming group has now completed its long‑flagged Nasdaq delisting, shifted its capital‑markets home to the Australian Securities Exchange (ASX), refreshed its employee stock purchase plan and pushed through a wave of governance and debt filings — all converging around today’s 13 November 2025 milestone. explore.investors.lnw.com+1 Key takeaways Nasdaq delisting lands – and index providers catch up Light & Wonder first told investors in October that it would voluntarily delist its common stock from Nasdaq and consolidate its primary listing on the ASX. The company
13 November 2025
·····
Russia’s First AI Humanoid Robot ‘AIDOL’ Face‑Plants in Moscow Debut, Exposing the Gap Between Hype and Reality

Russia’s First AI Humanoid Robot ‘AIDOL’ Face‑Plants in Moscow Debut, Exposing the Gap Between Hype and Reality

Russia’s much‑publicised AI humanoid robot, AIDOL, stumbled and fell during its first public appearance on a Moscow stage, turning a triumphant tech showcase into a viral lesson on the limits of current robotics – and the pressure on Russia’s sanctioned tech sector to prove itself. A debut choreographed for glory – and for memes On Tuesday, 11 November, a black‑and‑silver humanoid robot waddled onto the stage at a Moscow technology showcase, flanked by two handlers and backed by “Gonna Fly Now” from Rocky. State and local media had trailed the event as the unveiling of one of Russia’s first AI‑powered
13 November 2025
···
Stock Market Today, Nov. 13, 2025: Dow Slides as Disney Plunges and Tech Stocks Drop After Trump Ends Record Shutdown

Stock Market Today, Nov. 13, 2025: Dow Slides as Disney Plunges and Tech Stocks Drop After Trump Ends Record Shutdown

Dow Jones pulls back from a fresh record above 48,000 as Wall Street digests the end of the longest U.S. government shutdown, a sharp Disney sell-off, and renewed pressure on Big Tech. Market overview: Wall Street takes a breather after record highs U.S. stocks traded lower on Thursday, November 13, 2025, as investors pivoted from celebrating fresh records to worrying about what comes next for the economy and interest rates. By early trading, the major indexes were down across the board: The pullback comes just one day after the Dow jumped more than 300 points to close around 48,254, its
13 November 2025
····
John Hancock Group of Funds Adds Two Independent Trustees as Chicago’s John Hancock Prep Rallies Support for Thanksgiving ‘Harvest Havoc’ Tournament

John Hancock Group of Funds Adds Two Independent Trustees as Chicago’s John Hancock Prep Rallies Support for Thanksgiving ‘Harvest Havoc’ Tournament

The John Hancock name is in the news on two very different fronts today: on Wall Street, where the John Hancock Group of Funds has named two seasoned financial leaders as independent trustees, and on Chicago’s Southwest Side, where John Hancock College Prep is asking the community to help tip off its inaugural Thanksgiving basketball tournament.PR Newswire+1 Although the fund complex and the public high school are unrelated organizations that simply share a name, both stories center on stewardship — of investors’ money on one hand, and of young athletes and their community on the other. John Hancock Group of
13 November 2025
··
Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades

Cellebrite (CLBT) Soars on Q3 2025 Earnings Beat, Raised Guidance and Fresh Analyst Upgrades

Digital intelligence specialist Cellebrite DI Ltd. (Nasdaq: CLBT) is jumping on Thursday, November 13, 2025, after posting stronger‑than‑expected third‑quarter results and lifting its 2025 outlook, prompting multiple bullish calls from Wall Street. CLBT stock jumps as investors digest Q3 beat Cellebrite shares are rallying sharply in today’s session. As of mid‑afternoon trading on November 13, CLBT is changing hands around $19.80, up roughly 24% from the pre‑earnings close, on heavy volume. Benzinga Pre‑market, the stock was already up more than 20%, after the company reported better‑than‑expected Q3 2025 numbers and raised its full‑year guidance, drawing trader attention to the name.
13 November 2025
····
Sealed Air (SEE) Soars to 52‑Week High as Clayton Dubilier & Rice Weighs Take‑Private Deal

Sealed Air (SEE) Soars to 52‑Week High as Clayton Dubilier & Rice Weighs Take‑Private Deal

Sealed Air Corporation (NYSE: SEE), maker of Bubble Wrap, jumped to a 52‑week high on November 13, 2025, as private‑equity firm Clayton Dubilier & Rice reportedly explores a take‑private deal. Here’s what’s driving SEE stock today, including fresh buyout rumors, Q3 2025 earnings, analyst targets, and key risks. Sealed Air Corporation (NYSE: SEE) is suddenly one of Wall Street’s hottest tickers. The packaging company behind Bubble Wrap and Cryovac is rallying sharply today after multiple reports that private‑equity giant Clayton, Dubilier & Rice (CD&R) is exploring a takeover that could take Sealed Air private. By late morning on Thursday, SEE
13 November 2025
····
IRS Raises 2026 401(k) and IRA Contribution Limits: New $24,500 Cap, Higher Catch‑Ups and Roth Rules Explained

IRS Raises 2026 401(k) and IRA Contribution Limits: New $24,500 Cap, Higher Catch‑Ups and Roth Rules Explained

On Thursday, November 13, 2025, the IRS released Notice 2025‑67, confirming the official contribution limits for tax‑advantaged retirement accounts in 2026. The headline change: workers will be allowed to defer up to $24,500 into 401(k)s and similar workplace plans next year—$1,000 more than in 2025—while the IRA limit increases to $7,500. IRS+1 The announcement immediately drew coverage from major outlets including MarketWatch, the Wall Street Journal, CNBC, and the Detroit Free Press, all highlighting that older savers get even more room via expanded “catch‑up” contributions and that high earners will face new Roth rules starting in 2026. linkedin.com+3MarketWatch+3The Wall Street
13 November 2025
·
Outlook Therapeutics (OTLK) Soars as FDA Accepts ONS‑5010 BLA and Sets December 31, 2025 Review Date

Outlook Therapeutics (OTLK) Soars as FDA Accepts ONS‑5010 BLA and Sets December 31, 2025 Review Date

Outlook Therapeutics (NASDAQ: OTLK) shares jumped today after the U.S. FDA accepted the company’s resubmitted Biologics License Application (BLA) for ONS‑5010/LYTENAVA, its bevacizumab-based eye drug for wet AMD, and set a PDUFA review date of December 31, 2025. Here’s what investors need to know. What Outlook Therapeutics announced today This morning, Outlook Therapeutics, Inc. (NASDAQ: OTLK) announced that the U.S. Food and Drug Administration has accepted the company’s resubmitted Biologics License Application for ONS‑5010 (bevacizumab‑vikg)/LYTENAVA, its investigational ophthalmic formulation of bevacizumab for the treatment of wet age‑related macular degeneration (wet AMD). GlobeNewswire+2Outlook Therapeutics+2 According to the company’s press release and
13 November 2025
····
Northland Power (TSX:NPI) Stock Plunges as Q3 2025 Revenue Beat is Overshadowed by 40% Dividend Cut and Hai Long Delay

Northland Power (TSX:NPI) Stock Plunges as Q3 2025 Revenue Beat is Overshadowed by 40% Dividend Cut and Hai Long Delay

Northland Power Inc. (TSX: NPI, NPI.TO) is under heavy pressure today after reporting third‑quarter 2025 results, cutting its dividend by 40% and warning that delays at its flagship Hai Long offshore wind project could hit 2026 revenues. The stock is trading around C$19 today, down more than 20% from Wednesday’s close near C$25, according to intraday quote data. StockInvest+1 Key Takeaways for Investors Q3 2025: Revenue Beat, Heavy Impairment Northland Power’s Q3 2025 numbers paint a mixed picture: strong operations and cash flow on one side, a sizeable accounting hit on the other. According to the company’s Q3 press release:
13 November 2025
·····
Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Clearmind Medicine (CMND) Stock Soars as FDA‑Regulated Alcohol Use Disorder Trial Expands to Hadassah – November 13, 2025

Vancouver / Jerusalem – November 13, 2025 – Shares of Clearmind Medicine Inc. (NASDAQ: CMND), a clinical‑stage psychedelic and neuroplastogen biotech company, jumped sharply on Thursday after the firm announced final approval to expand its FDA‑regulated Phase 1/2a clinical trial for Alcohol Use Disorder (AUD) to Hadassah Medical Center in Jerusalem. GlobeNewswire+1 At the same time, Clearmind filed a new Form 6‑K detailing a registered direct offering of shares and pre‑funded warrants, adding fresh capital but also raising dilution questions for investors. Stock Titan Below is a full breakdown of today’s key developments and what they mean for CMND stock.
13 November 2025
····
Manulife (MFC.TO) Hits Record High on Q3 Beat, India Mahindra JV and $350M Longevity Push

Manulife (MFC.TO) Hits Record High on Q3 Beat, India Mahindra JV and $350M Longevity Push

Manulife Financial Corporation (TSX: MFC, NYSE: MFC) has packed a full strategic reset, fresh Asian expansion, and a record quarter of earnings momentum into just a couple of days — and the market is cheering. Shares of Manulife jumped as much as 3.3% today to an all‑time high of C$49.82 in Toronto after the Canadian insurer beat Q3 estimates, unveiled a refreshed growth strategy, and confirmed a 50:50 life‑insurance joint venture in India with Mahindra & Mahindra. Reuters+1 Below is a full rundown of everything investors need to know about Manulife’s news flow around 13 November 2025 — from earnings
13 November 2025
···
Alien Probe or Cosmic Relic? Interstellar Comet 3I/ATLAS Baffles Scientists (updated 27.10.2025)

3I/ATLAS Today (Nov. 13, 2025): Interstellar comet’s tail keeps growing, ‘radio signal’ confirmed natural, and a different ATLAS comet fragments

Published Thursday, November 13, 2025 Fresh observations today keep 3I/ATLAS—the third confirmed interstellar object—firmly in the “strange but natural comet” camp. Meanwhile, a different ATLAS‑discovered comet in our solar system, C/2025 K1 (ATLAS), is visibly fragmenting. Here’s what changed today, what didn’t, and how to tell these two “ATLAS comets” apart. ScienceAlert+2NASA Science+2 What’s new today (Nov. 13) The science behind the week’s biggest talking points The “radio signal” explained.MeerKAT detected OH absorption at the familiar radio frequencies used to trace water loss in comets. That’s direct evidence that 3I/ATLAS is venting water as it warms—exactly what a coma should
13 November 2025
···
1 … 2,187 2,188 2,189 2,190 2,191 … 2,710

Stock Market Today

iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026
iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.
Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

7 February 2026
Hongkong Land shares fell 4.2% to US$8.18 in Singapore on Friday after the company disclosed a buyback of 170,000 shares at US$8.5252 each on Feb. 5, with plans to cancel them. The drop followed a volatile week marked by a new Singapore real estate fund launch and an expanded buyback programme. Investors are watching for the group’s annual results on March 5.
Go toTop